FDA 483 - F2 Chemicals LTD - November 06, 2008

An FDA Form 483 was issued to F2 Chemicals LTD, an API Producer in Preston, Lancashire, U.K., on November 6, 2008, following an inspection by the U.S. Food and Drug Administration. This document outlines significant observations made by the FDA representatives regarding the firm's manufacturing practices.The primary observation concerned the company's analytical testing procedures. Specifically, F2 Chemicals LTD was cited for not consistently using a characterized reference standard for assay and purity tests conducted on stability study samples and finished products since a certain date. While an original method from 1997 included such a standard, the firm's current method relies on a mixture prepared by an unaudited external company. This raises concerns about the reliability and control over crucial analytical data.A second observation highlighted a lack of information regarding cleaning and chemical agents used by a third-party company responsible for servicing and cleaning reused cylinders. This absence of control over critical cleaning processes can pose risks to product quality and safety.These observations signify potential deviations from good manufacturing practices, requiring F2 Chemicals LTD to address the identified issues promptly. The issuance of a Form 483 indicates areas where the firm's operations do not align with regulatory expectations, necessitating a comprehensive response and implementation of corrective actions to ensure product quality and compliance.